DrugRepV Browse Page

DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Rluc assay are 10

DrugRepV_ID	Antiviral Name	Drug type	Primary Indication	Secondary Indication	Strain	Pathways	Assay	Activity	Clinical Status	References
DrugRepV_2986	Apigenin	NA	NA	Chikungunya virus	CHIKV replicon	NA	Rluc assay	Decrease (50 %)	Experimental	22205980
DrugRepV_2987	Chrysin	Plant extract	NA	Chikungunya virus	CHIKV replicon	NA	Rluc assay	Decrease (50 %)	Experimental	22205980
DrugRepV_2988	Naringenin	NA	NA	Chikungunya virus	CHIKV replicon	NA	Rluc assay	Decrease (50 %)	Experimental	22205980
DrugRepV_2989	Silybin	NA	NA	Chikungunya virus	CHIKV replicon	NA	Rluc assay	Decrease (50 %)	Experimental, Investigational	22205980
DrugRepV_2990	Prothipendyl	Nervous System	Dementia | Depression | Schizophrenia | Anxiety Disorders | Psychosomatic Disorders	Chikungunya virus	CHIKV replicon	NA	Rluc assay	Decrease (50 %)	Investigational	22205980
DrugRepV_2991	Ribavirin	Antiinfectives For Systemic Use	Hepatitis C virus	Chikungunya virus	CHIKV replicon	NA	Rluc assay	Decrease (50 %)	Approved	22205980
DrugRepV_2992	Mycophenolic Acid	Antineoplastic and Immunomodulating Agents	Organ rejection (immunosuppressants)	Chikungunya virus	CHIKV replicon	NA	Rluc assay	Decrease (50 %)	Approved	22205980
DrugRepV_2993	6-Azauridine	NA	Cancer	Chikungunya virus	CHIKV replicon	NA	Rluc assay	Decrease (50 %)	NA	22205980
DrugRepV_2994	3-NH2-3-deoxyadenosine	NA	NA	Chikungunya virus	CHIKV replicon	NA	Rluc assay	Decrease (50 %)	NA	22205980
DrugRepV_3007	Imipramine	Nervous System	Depression	Chikungunya virus	La Reunion strain	NA	Rluc assay	Decrease (1x 103 logs)	Approved	28600536